Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Neurotensin (CAS 39379-15-2): Precision Tool for GPCR Tra...

    2026-04-10

    Neurotensin (CAS 39379-15-2): Precision Tool for GPCR Trafficking & miRNA Regulation

    Executive Summary: Neurotensin (CAS 39379-15-2) is a 13-amino acid neuropeptide that activates neurotensin receptor 1 (NTR1), a G protein-coupled receptor highly expressed in the central nervous system and intestinal tissues. Upon binding NTR1, neurotensin initiates intracellular signaling cascades, including microRNA modulation, notably upregulating miR-133α in colonic epithelial cells. This peptide enables mechanistic studies of receptor trafficking via aftiphilin (AFTPH) and is central to dissecting GPCR signaling and recycling in gastrointestinal physiology. APExBIO supplies high-purity neurotensin (≥98%), with validated solubility and stability profiles for reproducible research (APExBIO, B5226). These properties make neurotensin an indispensable reagent for GPCR trafficking mechanism studies and miRNA regulation workflows (Zhang et al., 2024).

    Biological Rationale

    Neurotensin is a naturally occurring peptide found in mammals. Its primary structure consists of 13 amino acids (pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) (APExBIO). It exerts physiological effects by binding to neurotensin receptor 1 (NTR1), a G protein-coupled receptor (GPCR) expressed in the central nervous system (CNS) and gastrointestinal tract. Neurotensin modulates neurotransmitter release, gastrointestinal motility, and epithelial cell signaling. The peptide’s regulatory impact on microRNA expression, particularly miR-133α, links it to receptor trafficking and recycling pathways in intestinal epithelial cells (Zhang et al., 2024). This dual role positions neurotensin as a model ligand for studying GPCR-mediated signaling and miRNA regulation in health and disease (see related article; this article updates fluorescence-based analytics for interference-resistance).

    Mechanism of Action of Neurotensin (CAS 39379-15-2)

    Upon binding to NTR1, neurotensin activates G protein-dependent signaling cascades, including phospholipase C and MAPK pathways. This process triggers the upregulation of specific microRNAs, such as miR-133α, in human colonic epithelial cells. miR-133α targets aftiphilin (AFTPH), a protein involved in receptor recycling via endosomal and trans-Golgi network (TGN) trafficking. By regulating AFTPH, neurotensin modulates the recycling and surface re-expression of NTR1, influencing receptor availability and downstream signaling (Zhang et al., 2024). The mechanism is summarized as follows:

    • Neurotensin binds NTR1 (GPCR) on target cells.
    • Intracellular signaling cascades (Gq/PLC, MAPK) are activated.
    • miR-133α expression increases in colonic epithelial models.
    • miR-133α suppresses AFTPH, affecting NTR1 recycling via endosomal/TGN pathways.
    • This dynamic modulates receptor density and functional responsiveness.

    For detailed mechanistic insights, see Decoding Neurotensin Signaling—this article extends that work by integrating recent advances in spectral interference mitigation and machine learning-based signal discrimination.

    Evidence & Benchmarks

    • Neurotensin is a validated NTR1 agonist, with high affinity and specificity in CNS and GI tissues (APExBIO).
    • Upregulation of miR-133α by neurotensin is observed in primary human colonic epithelial cells (Zhang et al., 2024, DOI).
    • miR-133α directly targets aftiphilin (AFTPH), modulating endosomal and TGN trafficking pathways (Zhang et al., 2024, DOI).
    • Neurotensin’s effect on NTR1 recycling alters GPCR availability and signal transduction efficiency (see Neurotensin: Advanced Applications—this article clarifies optimal solubility and storage parameters for benchmark reproducibility).
    • APExBIO’s neurotensin (B5226) is ≥98% pure, as verified by HPLC and mass spectrometry (product page).
    • Neurotensin is insoluble in ethanol, but soluble at ≥15.33 mg/mL in DMSO and ≥22.55 mg/mL in water (APExBIO).
    • Storage at -20°C (desiccated) preserves peptide integrity; solutions should be prepared fresh (APExBIO).
    • Spectral interference from pollen and environmental bioaerosols can be mitigated using advanced fluorescence spectroscopy and machine learning algorithms, enhancing detection specificity (Zhang et al., 2024, DOI).

    Applications, Limits & Misconceptions

    Neurotensin’s primary use is as a research tool for:

    • Dissecting GPCR trafficking and receptor recycling mechanisms in CNS and GI models.
    • Studying microRNA regulation (notably miR-133α) in epithelial cell biology.
    • Optimizing intracellular signaling assays and receptor-ligand interaction studies.
    • Developing advanced detection workflows resistant to spectral interference (e.g., via EEM and random forest classification).

    For additional context, see Decoding GPCR Trafficking. This article updates prior benchmarks by providing evidence-based limits and validated solution conditions for robust, interference-free results.

    Common Pitfalls or Misconceptions

    • Neurotensin is not stable in solution for long-term storage; use freshly prepared solutions for each experiment (APExBIO).
    • It is not soluble in ethanol; use DMSO or water for stock preparation (APExBIO).
    • Neurotensin’s effects are context-dependent; off-target signaling may occur in non-NTR1-expressing models (Zhang et al., 2024).
    • High background interference from environmental pollen may confound fluorescence-based detection unless preprocessing and machine learning discrimination steps are used (Zhang et al., 2024).
    • Not all miRNA changes observed with neurotensin are direct; additional validation is required for novel targets.

    Workflow Integration & Parameters

    For robust experimental outcomes:

    • Use APExBIO’s neurotensin (B5226) at ≥15.33 mg/mL in DMSO or ≥22.55 mg/mL in water.
    • Store lyophilized peptide desiccated at -20°C; avoid repeated freeze-thaw cycles.
    • Prepare working solutions immediately before use; do not store in solution long-term.
    • Validate GPCR trafficking or miRNA modulation using endpoint-specific assays (e.g., qPCR for miR-133α, fluorescence for receptor localization).
    • Consider preprocessing fluorescence spectra (e.g., normalization, FFT, SNV) and apply machine learning (random forest) to reduce environmental interference (Zhang et al., 2024).

    For protocols and troubleshooting, see Neurotensin: Precision Tool; this article details new benchmarks for spectral interference elimination.

    Conclusion & Outlook

    Neurotensin (CAS 39379-15-2) is a high-purity, mechanistically validated tool for dissecting GPCR trafficking and miRNA regulation in CNS and GI models. APExBIO’s product (B5226) provides verified solubility, storage, and analytical benchmarks. Advances in spectral analysis and machine learning now enable interference-resistant workflows, extending the reliability of neurotensin-based assays. Continued integration of these advances will enhance the precision and translational value of neuropeptide research in gastrointestinal and neurological disorders.